Antiaging & Longevity Stem Cell Protocol

Investigational Mesenchymal Cell Program for Healthy Aging & Functional Capacity

Important Medical Notice:

The antiaging protocol remains an investigational procedure centered on intrinsic capacity, prevention, and measurable longevity goals. Chronological age alone does not constitute a medical indication for cell therapy. It must not be presented as a cure, age reversal, guaranteed multiorgan regeneration, disease prevention, or extended lifespan.

Institutional Provider Details:

  • Legal Entity: STEM CELLS KYRON COLOMBIA SCKC

  • Facility Address: Calle 6 Oeste #24f-13, Cali, Colombia

  • Medical Director: Dr. Carlos Eduardo Rojas Martínez, MD (CEO)

  • Cell Processing Laboratory: TRUSTEM BANK

  • Clinical Patient Manager: Daniel Sanz

SCOPE OF SERVICE

(INCLUSIONS & EXCLUSIONS)

Included in the Package

Exclusions & Out-of-Pocket Expenses

CLINICAL ELIGIBILITY & REQUIRED DOCUMENTS

Potential Candidates for Evaluation:

  • Adults with concrete functional or clinical goals and a clear measurable baseline.

  • Capacity to provide informed consent and adhere to monitoring and remote follow-up.

  • Medical stability and prior evaluation of treatable causes of fatigue, weakness, or functional decline.

  • Realistic goals with explicit acceptance that rejuvenation or extended lifespan cannot be guaranteed.

  • Commitment to maintaining ongoing primary preventive care, exercise, nutrition, and sleep hygiene.

Situations Requiring Additional Evaluation or Exclusion:

  • Active fever, infection, bacteremia, or unresolved acute illness.

  • Rapid unexplained functional loss, chest pain, syncope, or unworked-up neurological deficits.

  • Active or suspected cancer, or decompensated cardiovascular, pulmonary, renal, hepatic, or psychiatric conditions.

  • Uncontrolled coagulopathy, thrombotic risk, relevant immunosuppression, pregnancy, or known component allergies.

  • Advanced frailty or severe cognitive decline lacking adequate caregiver support.

  • Unrealistic expectations of guaranteed youthful appearance or replacing effective preventive medicine.

  • Detailed medical history covering chronic diagnoses, falls, functional capacity, cognition, mood, sleep, and nutrition.

  • Complete list of current medications, hormones, peptides, supplements, antiplatelets, anticoagulants, and allergies.

  • Cardiovascular, oncological, metabolic, renal, hepatic, respiratory, and autoimmune background.

  • Recent baseline lab work: blood pressure, CBC, renal/hepatic panels, glucose/HbA1c, lipid panel, ECG, or specialty imaging.

  • Emergency contacts and government-issued identification.

PROTOCOL SPECS & 4-DAY TIMELINE

Cellular Product Specifications:

  • Cell Type: Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs).

  • Manufacturing Laboratory: TRUSTEM BANK.

  • Dose & Route: Individualized per case evaluation; administered via Intravenous (IV) infusion.

  • Quality Assurance: Certified post-thaw viability, sterility, endotoxin, mycoplasma clearance, and identity marker reports.

4-Day Clinical Itinerary:

  • Pre-Travel (1 Week Prior): File review, clinical pre-selection, and customized budget approval.

  • Day 1 (Arrival in Cali): On-site physical assessment, medical consultation, and required baseline tests.

  • Day 2 (Procedure Day): Intravenous administration and clinical post-infusion monitoring.

  • Day 3 (Local Observation): Clinical stability check, symptom tracking, and local observation.

  • Day 4 (Travel Clearance): Final medical discharge review and authorization for return travel.

  • Remote Follow-Up: Scheduled clinical tracking at Weeks 4, 14, 36, and 52.

POST-PROCEDURE RECOVERY & RISK DISCLOSURE

Post-Procedure Recovery Guidelines:

Post-Procedure Recovery Guidelines:

  • First 24–48 Hours: Strictly follow observation instructions. Seek urgent medical care for persistent fever, shortness of breath, chest pain, syncope, neurological deficit, or allergic reaction.

  • First Week: Maintain progressive mobilization and adequate hydration. Log temperature, blood pressure, fatigue, or skin rashes.

  • After Return Home: Share your medical summary with your primary care physician or geriatrician. Continue all core preventive health measures.

General Risks and Possible Complications:

  • Local vein irritation, phlebitis, bruising, or pain at the infusion site.

  • Transient low-grade fever, headache, nausea, or inflammatory fatigue.

  • Infusional or allergic reactions, including temporary hypotension or dyspnea.

  • Vascular, thrombotic, or volume overload events.

  • Absence of clinical benefit or financial loss.

FREQUENTLY ASKED QUESTIONS

1. Is cell therapy approved as a routine antiaging treatment?

No. It must not be presented as an approved routine antiaging treatment. Its investigational status must be reviewed prior to consent.

2. What does the starting price include?

The $7,000 USD figure is an initial planning estimate. You will receive an itemized quote separating consultations, tests, cell product, administration, and follow-up.

3. Can this treatment rejuvenate organs or extend lifespan?

No. Reversal of chronological age, multiorgan regeneration, or guaranteed longevity expansion cannot be promised.

4. What information should I request about the cellular product?

Request written details on cell source, donor criteria, laboratory provider, identity markers, viability, sterility, endotoxin testing, and dosage.

5. How long must we stay in Cali, Colombia?

The baseline stay is 4 days, but flexibility is essential depending on clinical response, observation needs, and travel readiness.

6. Should I stop my current medications or hormones?

No. Never stop or alter prescribed medications, hormones, or supplements on your own without direct medical instruction.

7. What happens if an issue arises after returning home?

You will receive a written contact plan and medical discharge summary before departing to coordinate with your home medical team.

8. Does a registered clinical trial guarantee effectiveness?

No. Trial registration reflects research status, not regulatory approval or guaranteed benefit for an individual.

9. How can I verify the clinic and provider credentials?

Request active facility licenses, treating physician credentials, laboratory certifications, and emergency referral protocols.

10. Should I obtain an independent medical opinion?

Yes. An independent clinical review helps evaluate individual risks, preventive alternatives, and travel suitability.

PRE-DECISION CHECKLIST

Request Your Healthy Aging Assessment

Speak with our specialists to review your longevity goals, functional capacity, and personalized cell therapy evaluation plan.

Call us

+ (1) 305 400 1476
+ (57) 315 399 5608

Email us

daniel@stemcellskyroncolombia.com drc@stemcellskyroncolombia.com

Visit us

Cl. 6 Oe. #N° 24F - 13, Miraflores, Cali, Valle del Cauca